General Mills (NYSE: GIS) posted net sales of $18.42 billion for FY2026 (May 26, 2025 – May 31, 2026, 53 weeks), down 5% year over year. Operating income collapsed 72% to $886 million, with the operating margin contracting 1,166 basis points to 4.8%. A $1.5 billion North America Pet goodwill impairment, brand intangible asset impairment charges, and a write-down on the Brazil business held for sale weighed on results, driving the company to a net loss of $0.16 per diluted share, flipping from profit to loss.
1. Consolidated Balance Sheet Analysis
1-1. Key Asset Items
The 10-K excerpt does not include a detailed balance sheet line breakdown; only the following two figures are explicitly confirmed.
| Item | End of FY2026 ($ billions) | Note |
|---|---|---|
| Goodwill + Indefinite-lived intangible assets | 20.6 | Brand assets including Blue Buffalo, Pillsbury, and Häagen-Dazs (10-K Item 1A) |
| Total debt + Noncontrolling interests | 13.6 | Core financial leverage burden (10-K Item 1A) |
The most notable figure is the $20.6 billion in goodwill and indefinite-lived intangible assets. The excerpt does not include a total assets line, so no asset-ratio calculation was made; in absolute terms, the figure already exceeds the company's annual net sales ($18.42 billion).
Total "restructuring, transformation, impairment, and other exit costs" for FY2026 were $2.971 billion (FY2025: $78 million), a sharp increase. The major line items the 10-K identifies individually are: ① North America Pet reporting unit goodwill impairment $1.500 billion (non-cash); ② Nudges, Uncle Toby's, and True Chews brand intangible asset impairment $0.303 billion (non-cash); ③ Brazil business held-for-sale write-down $1.032 billion (non-cash); ④ supply chain competitiveness restructuring $0.095 billion; and announced restructuring and transformation charges $0.060 billion. However, the sum of these individual items ($2.990 billion) does not reconcile to the disclosed total of $2.971 billion — offsetting items not included in the excerpt mean this list is not exhaustive.
The company separately disclosed that Blue Buffalo and Progresso brands carry reduced headroom and are under continuing monitoring, signaling the possibility of additional impairment. Even a modest deterioration in growth rate or discount rate assumptions could trigger further large impairment charges.
1-2. Debt Structure — Total Debt and Noncontrolling Interests $13.6B
The company states total debt and noncontrolling interests at $13.6 billion. The company itself flags the risk that a credit rating downgrade could reduce financing flexibility and trigger covenant violations — meaning leverage is the binding constraint on M&A, buybacks, and dividends. In FY2026, dividends ($1.315 billion) plus net share repurchases ($0.500 billion) totaled approximately $1.815 billion, already exceeding FCF of $1.626 billion.
1-3. Capital Structure
The FY2026 net loss of $87.6 million modestly eroded retained earnings, while shareholder returns remained at approximately $1.8 billion. Shareholder returns outpaced earnings generation, and the remaining buyback authorization stands at 26,897,169 shares (under the 100 million share program approved June 27, 2022).
2. Consolidated Income Statement Analysis
2-1. Key Revenue Metrics
| Item | FY2025 | FY2026 | Change |
|---|---|---|---|
| Net sales ($ millions) | 19,486.6 | 18,424.6 | -5% |
| Cost of sales | 12,754 | 12,229 | -525 million |
| Gross margin | 34.6% | 33.6% | -92bp |
| SG&A | 3,445 | 3,388 | -57 million |
| Operating income | — | 885.8 | -72% |
| Operating margin | — | 4.8% | -1,166bp |
| Adjusted operating profit | — | 2,811.5 | -16% (constant currency) |
| Net earnings attr. to General Mills | Profit | (87.6) | -104% |
| Diluted EPS ($) | Profit | (0.16) | -104% |
| Adjusted diluted EPS ($) | — | 3.55 | -16% (constant currency) |
FY2026 figures and changes are as reported in the 10-K. FY2025 net sales is the comparative figure as stated in the 10-K; FY2025 cost of sales and SG&A are back-calculated from the 10-K-disclosed changes of -$525 million and -$57 million, respectively. FY2025 operating income, adjusted operating profit, and adjusted EPS absolute values are not available in this excerpt and are therefore omitted from the table.
Revenue must be read through two separate bridges. The 10-K presents reported and organic metrics separately.
- Reported basis (-5%): Volume -8pp, price/mix +2pp, foreign exchange +1pp. (The volume figure captures the full impact of the yogurt divestiture, which inflates the decline.)
- Organic basis bridge (-5%): Organic volume -1pp + organic price/mix -1pp = organic net sales -2pp, plus foreign exchange +1pp, divestitures/acquisitions (yogurt sale, Whitebridge acquisition) -6pp, and 53rd-week benefit +2pp.
The critical and easily overlooked detail is that organic price/mix was negative (-1pp), not positive. The 10-K states that the organic net sales decline stemmed from "lower organic pound volume and unfavorable organic net price realization and mix." The FY2026 underperformance was therefore not just a volume problem — the company accepted price concessions (which it terms "price investments") and still could not hold volume. Management noted in its FY2027 guidance that "foundational pricing actions were completed in FY2026," signaling the price lever has been exhausted.
Notably, North America Retail organic pound volume came in at -1%, which management explicitly acknowledged as falling short of the company's own target.
The decisive drivers of the GAAP operating income collapse were: (1) goodwill and brand intangible asset impairment charges; (2) the Brazil held-for-sale write-down; and (3) higher input costs. These were partially offset by a net gain on divestitures of $1.049 billion, including the U.S. yogurt business sale.
2-2. Fixed vs. Variable Costs
- Variable costs (raw materials, energy, logistics): Cost of sales declined $525 million in total — the two disclosed drivers being a $1.009 billion reduction from lower volume and a $506 million increase from "product rate and mix" (together accounting for $503 million of the $525 million decline; the remaining $22 million reflects items not separately identified in the excerpt). The 10-K does not label this increase explicitly as raw material inflation, though it separately identifies rising input costs as a margin headwind. For FY2027, the company projects 4–5% input cost inflation.
- Fixed costs (marketing, labor, depreciation): SG&A fell $57 million but rose 70 basis points as a percentage of net sales — clear negative operating leverage from the top-line contraction. Advertising and media spend increased even as other administrative costs and divestiture effects drove the headline reduction.
- The company targets $3.0 billion in cumulative cost savings over four years through FY2030 ($2.0 billion HMM + $1.0 billion global transformation and other), with a minimum of $750 million targeted for FY2027 alone. For reference, the company reported HMM savings equivalent to 5% of cost of sales in FY2026.
3. Cash Flow Analysis
| Item ($ millions) | FY2026 |
|---|---|
| Cash from operations | 2,166 |
| Capital expenditures | (540) |
| Free cash flow (FCF) | 1,626 |
| Dividends paid | (1,315) |
| Net share repurchases | (500) |
FCF conversion — measured against adjusted after-tax earnings — came in at approximately 84%, below the long-term target of at least 95%. Total shareholder returns ($1.815 billion) exceeded FCF ($1.626 billion), with the gap funded not by incremental debt but by proceeds from the U.S. yogurt business divestiture ($1.798 billion). Accordingly, net debt declined by $1.426 billion in FY2026.
FY2026 shareholder returns therefore exceeded FCF by $189 million, with that gap funded by a modest draw on the one-time divestiture proceeds. Whether the company can sustain the same level of returns in FY2027 — when that source is exhausted — is the central question. Management guided for FCF conversion recovering to approximately 95% in FY2027.
4. 5 Key Issues
- Walmart concentration at 22% — A single customer accounts for 22% of consolidated net sales and 31% of North America Retail net sales. A retailer inventory policy change alone can move quarterly results materially. (The company cited "retailer inventory changes" as the primary driver of the 3-percentage-point organic sales slowdown in North America Pet.)
- GLP-1 weight-loss drug demand risk — The 10-K risk factors explicitly cite "the impact of weight loss drugs" as a driver of shifts in consumer eating behavior. The portfolio — heavily weighted toward snacks, cereals, and ice cream — faces a structural headwind.
- Renewed impairment risk — The company itself flagged Blue Buffalo and Progresso as carrying reduced headroom. The $20.6 billion intangible asset base is acutely sensitive to changes in discount rate and growth assumptions.
- Tariff and geopolitical risk — International net sales represent 20% of the total. The 10-K identifies "tariffs recently imposed or threatened by the U.S. and retaliatory measures" as an international segment risk, creating a dual input-cost and currency headwind.
- FY2027 guidance points lower — Organic net sales -1.5% to +0.5%, adjusted operating profit -8% to -13% (constant currency), adjusted diluted EPS $3.00–$3.20 (versus FY2026's $3.55, implying -10% to -15%, midpoint approximately -13%). The 53rd-week lap, incentive compensation normalization, and FY2026 divestiture impacts alone create approximately 9 percentage points of operating profit headwind and approximately 11 percentage points of EPS headwind.
5. Key Takeaways and Outlook
Bull case: HMM cost savings (equivalent to approximately 4% of annual cost of sales going forward) and global transformation execution on plan could drive margin recovery from the second half of FY2027. The yogurt divestiture removed a low-growth asset, and the portfolio repositioning toward pet food (Whitebridge acquisition) is underway.
Bear case: (1) The organic net sales -2% trajectory continues and the FY2027 guidance range (-1.5% to +0.5%) is breached on the downside; (2) additional Blue Buffalo and Progresso impairment charges hit GAAP earnings again; (3) with total debt and noncontrolling interests at $13.6 billion, once divestiture proceeds are exhausted, sustaining current shareholder returns requires either additional borrowing or a payout cut.
The market has begun to price in dividend risk. The board approved a quarterly dividend of $0.61 per share — unchanged from the prior quarter — alongside the FY2026 fourth-quarter earnings release. General Mills and its predecessors have not cut or suspended the dividend in 127 years, but with the share price down sharply from the start of the year, the dividend yield has exceeded 7% — a level that typically signals not "attractive income" but market skepticism about dividend sustainability. As documented above, FY2026 shareholder returns already exceeded FCF and the shortfall was bridged by asset sale proceeds, giving that skepticism a factual basis.
Investment thesis pivot points: General Mills is now a defensive stock that has lost its defensive premium. The elevated headline yield was created not by a larger numerator (a higher dividend) but by a collapsing denominator (a lower stock price). The three metrics to watch over the next 12 months are: whether FY2027 guidance is breached on the downside, the scale of any further impairment charges, and whether the dividend policy holds.
Disclaimer
This article is based on General Mills' publicly available Form 10-K filing and is provided for informational purposes only. It does not constitute investment advice or a recommendation to buy, sell, or hold any security. LineVest News is not a registered investment adviser. All content reflects the author's interpretation of publicly available disclosures and may contain errors or omissions. Readers should conduct their own due diligence and consult a qualified financial professional before making any investment decisions.